FTA Standards Development Program: Over-the-Counter and Prescription Drug Use in the Public Transit Industry, Final Report

This report includes background research and analysis on the need for new standards, recommended practices, guidance documents, or procedural considerations in the areas of prescription (Rx) and over-the-counter (OTC) medication risk management. Gaps that exist in current standards, recommended practices, or guidance documents available to the industry to address Rx/OTC use are identified, and findings are included that address the development or issuance of voluntary standards, protocols, guidelines, or recommended practices related to Rx/OTC risk management and associated topics.

• Record URL:
  • https://doi.org/10.21949/1520703
• Record URL:
  • https://www.transit.dot.gov/research-innovation/fta-standards-development-program-over-counter-and-prescription-drug-use-public
• Record URL:
  • https://rosap.ntl.bts.gov/view/dot/62543
• Corporate Authors:

  University of South Florida, Tampa

  Center for Urban Transportation Research
  4202 Fowler Avenue
  Tampa, FL  United States  33620-5373

  Federal Transit Administration

  Office of Research, Demonstration and Innovation
  1200 New Jersey Avenue, SE
  Washington, DC  United States  20590
• Authors:
  • Byrnes, Diana
• Publication Date: 2022-6

Language

• English

Media Info

• Media Type: Digital/other
• Features: Appendices; Figures; References; Tables;
• Pagination: 57p

Subject/Index Terms

• TRT Terms: Drug use; Medication; Public transit; Risk management; Standards
• Subject Areas: Policy; Public Transportation; Safety and Human Factors;

Filing Info

• Accession Number: 01848580
• Record Type: Publication
• Report/Paper Numbers: FTA Report No. 0217
• Files: NTL, TRIS, ATRI, USDOT
• Created Date: Jun 15 2022 10:47AM